Manufacturing Industry

Team breathes new life to indirect procurement: Boston Scientific creates centralized group of strategic sourcing experts to leverage its spend.

Purchasing, July, 2005 by Hannon, David

It's been an eventful 18 months for Boston Scientific. Within that period, the Natick, Mass.-based medical device maker has: received FDA clearance for its new product, the Taxus Express2 stent, in March 2004 after years of clinical trial reviews; progressed through a series of recalls of the same product through the summer of 2004; reported a 62% increase in revenues by year end, with sales jumping from $3.4 billion in 2003 to $5.6 billion in 2004; celebrated the company's 25th anniversary; and made four acquisitions.

The capper came in May 2005, when the firm was selected as the top company in the Boston area for 2005 by the Boston Globe, which evaluates Boston-based companies annually on a variety of issues, including return on equity, change in revenue and...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement